Department of Pharmaceutical Sciences;
College of Pharmacy and Health Sciences;
St.John’s University;
Queens;
NY 11439;
USA;
Department of Anesthesiology;
Stony Brook University Health Sciences Center;
Stony Brook;
NY 11794;
USA;
Department of Radiotherapy;
the Affiliated Jiangyin People’s Hospital of Nantong University;
Jiangyin 214400;
China;
MET inhibitor; Tepotinib; Multidrug resistance; ABCG2 transporter; Reversal agent; Combination treatment; Chemotherapy; In vivo study;